Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04820335 · ClinicalTrials.gov registry record · NA

Promoting Independence With Compensatory Cognitive Rehabilitation

A NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by University of Delaware.

Recruiting
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT04820335 is a NA study of Alzheimer Disease and Mild Cognitive Impairment that is actively recruiting participants, run by University of Delaware. The registered enrollment target is 65 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04820335, a NA study of Alzheimer Disease and Mild Cognitive Impairment, is actively recruiting participants, sponsored by University of Delaware.

RECRUITING
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

Alzheimer's disease (AD) is one of the leading causes of disability in older adults. Because pharmacological approaches do not seem to prevent or slow the disease, clinicians need non-pharmacological interventions that might help people with AD remain independent for as long as possible. This study aims to evaluate the effects of a new behavioral treatment, the Structured External Memory Aid Treatment (SEMAT), for adults with mild cognitive impairment (MCI) designed to promote independent living skills by explicitly teaching the use of strategies and tools to compensate for cognitive weaknesses. Aim 1: Evaluate the efficacy of the SEMAT for improving functional performance in a pilot randomized trial. Aim 2: Evaluate demographic, clinical, and neuropsychological predictors of treatment adherence. Aim 3: Develop and refine the SEMAT manual and other materials for training future interventionists.

Interventions

  • BEHAVIORAL Structured External Memory Aid Treatment (SEMAT)

Study Locations (1)

Delaware

  • University of Delaware - Newark

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2022-02-01
Est. Completion 2025-12-31
Phase NA

Sponsor

University of Delaware

106 total trials

What the Registry Record Tells You About NCT04820335

The ClinicalTrials.gov registry entry for NCT04820335 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Structured External Memory Aid Treatment (SEMAT) is the first listed.

NCT04820335 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.

Frequently Asked Questions

What is clinical trial NCT04820335 about?

NCT04820335 is a clinical study titled "Promoting Independence With Compensatory Cognitive Rehabilitation". Alzheimer's disease (AD) is one of the leading causes of disability in older adults. Because pharmacological approaches do not seem to prevent or slow the disease, clinicians need non-pharmacological interventions that might help people with AD remain independent for as long as possible. This study ...

What is the current status of trial NCT04820335?

This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2022-02-01. Estimated completion is 2025-12-31.

What conditions does trial NCT04820335 study?

This clinical trial studies the following conditions: Alzheimer Disease, Mild Cognitive Impairment.

What interventions are being tested in trial NCT04820335?

The interventions under investigation include: Structured External Memory Aid Treatment (SEMAT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04820335?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04820335 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.